A randomized double-blind study of N-(4-Hydroxyphenyl) retinamide (4-HPR) versus placebo in patients with cervical intraepithelial neoplasia (CIN) grade 2-3
Phase of Trial: Phase III
Latest Information Update: 05 Aug 2010
At a glance
- Drugs Fenretinide (Primary)
- Indications Cervical cancer
- Focus Therapeutic Use
- 24 Sep 2005 New trial record.